BioSyent
(TSXV) RX
BioSyent Financials at a Glance
Market Cap
CA$160.96M
Revenue (TTM)
CA$45.98M
Net Income (TTM)
CA$9.04M
EPS (TTM)
CA$0.79
P/E Ratio
17.47
Dividend
CA$0.21
Beta (Volatility)
-0.04 (Low)
Dividend
CA$0.21
Beta (Volatility)
-0.04 (Low)
Price
CA$14.00
Volume
2,260
Open
CA$14.00
Price
CA$14.00
Volume
2,260
Open
CA$14.00
Previous Close
CA$14.00
Daily Range
CA$13.95 - CA$14.00
52-Week Range
CA$10.65 - CA$15.80
Estimated Earnings Date
May 14, 2026
Dividend
CA$0.21
Beta (Volatility)
-0.04 (Low)
Price
CA$14.00
Volume
2,260
Open
CA$14.00
Previous Close
CA$14.00
Daily Range
CA$13.95 - CA$14.00
52-Week Range
CA$10.65 - CA$15.80
Estimated Earnings Date
May 14, 2026
RX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout BioSyent
Industry
Pharmaceuticals
Sector
Health CareEmployees
61
CEO
René C. Goehrum
Website
www.biosyent.comHeadquarters
Mississauga, ON L5N 6M1, CA
RX Financials
Key Financial Metrics (TTM)
Gross Margin
74%
Operating Margin
25%
Net Income Margin
20%
Return on Equity
22%
Return on Capital
25%
Return on Assets
14%
Earnings Yield
5.72%
Dividend Yield
1.50%
Payout Ratio
25.54%
Stock Overview
Market Cap
CA$160.96M
Shares Outstanding
11.50M
Volume
2.26K
Avg. Volume
5.71K
Financials (TTM)
Gross Profit
CA$32.11M
Operating Income
CA$11.31M
EBITDA
CA$12.17M
Operating Cash Flow
CA$9.62M
Capital Expenditure
-CA$54.04K
Free Cash Flow
CA$9.57M
Cash & ST Invst.
CA$28.65M
Total Debt
CA$841.10K
BioSyent Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
CA$13.91M
+26.7%
Gross Profit
CA$9.68M
+16.1%
Gross Margin
69.59%
N/A
Market Cap
CA$160.96M
N/A
Market Cap/Employee
CA$2.68M
N/A
Employees
60
N/A
Net Income
CA$2.34M
+1.1%
EBITDA
CA$3.66M
+8.4%
Quarterly Fundamentals
Net Cash
CA$5.65M
-65.6%
Accounts Receivable
CA$7.55M
+37.8%
Inventory
CA$11.29M
+114.0%
Long Term Debt
CA$813.20K
+3.1%
Short Term Debt
CA$4.43M
+998.5%
Return on Assets
14.46%
N/A
Return on Invested Capital
25.13%
N/A
Free Cash Flow
CA$2.93M
+462.8%
Operating Cash Flow
CA$2.95M
+511.2%